Annual CAPEX
$4.83 M
-$5.04 M-51.08%
31 December 2023
Summary:
Cytek Biosciences annual capital expenditures is currently $4.83 million, with the most recent change of -$5.04 million (-51.08%) on 31 December 2023. During the last 3 years, it has risen by +$3.28 million (+212.02%). CTKB annual CAPEX is now -51.08% below its all-time high of $9.87 million, reached on 31 December 2022.CTKB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.00 M
-$198.00 K-16.49%
30 September 2024
Summary:
Cytek Biosciences quarterly capital expenditures is currently $1.00 million, with the most recent change of -$198.00 thousand (-16.49%) on 30 September 2024. Over the past year, it has dropped by -$390.00 thousand (-28.00%). CTKB quarterly CAPEX is now -84.83% below its all-time high of $6.61 million, reached on 31 December 2022.CTKB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$4.39 M
-$390.00 K-8.16%
30 September 2024
Summary:
Cytek Biosciences TTM capital expenditures is currently $4.39 million, with the most recent change of -$390.00 thousand (-8.16%) on 30 September 2024. Over the past year, it has dropped by -$5.49 million (-55.58%). CTKB TTM CAPEX is now -55.58% below its all-time high of $9.88 million, reached on 30 September 2023.CTKB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.1% | -28.0% | -55.6% |
| 3 y3 years | +212.0% | -23.3% | +34.1% |
| 5 y5 years | - | - | - |
CTKB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.1% | +212.0% | -84.8% | +98.6% | -55.6% | +34.1% |
| 5 y | 5 years | -51.1% | +396.1% | -84.8% | +394.1% | -55.6% | +1160.6% |
| alltime | all time | -51.1% | +396.1% | -84.8% | +394.1% | -55.6% | +1160.6% |
Cytek Biosciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.00 M(-16.5%) | $4.39 M(-8.2%) |
| June 2024 | - | $1.20 M(+93.1%) | $4.78 M(-3.4%) |
| Mar 2024 | - | $622.00 K(-60.2%) | $4.94 M(+2.4%) |
| Dec 2023 | $4.83 M(-51.1%) | $1.56 M(+12.1%) | $4.83 M(-51.1%) |
| Sept 2023 | - | $1.39 M(+1.8%) | $9.88 M(+2.5%) |
| June 2023 | - | $1.37 M(+170.9%) | $9.63 M(+0.4%) |
| Mar 2023 | - | $505.00 K(-92.4%) | $9.59 M(-2.8%) |
| Dec 2022 | $9.87 M | $6.61 M(+474.8%) | $9.87 M(+116.7%) |
| Sept 2022 | - | $1.15 M(-13.4%) | $4.55 M(-3.4%) |
| June 2022 | - | $1.33 M(+70.3%) | $4.71 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $780.00 K(-39.8%) | $4.63 M(+6.2%) |
| Dec 2021 | $4.36 M(+182.1%) | $1.30 M(-0.9%) | $4.36 M(+33.4%) |
| Sept 2021 | - | $1.31 M(+4.6%) | $3.27 M(+34.2%) |
| June 2021 | - | $1.25 M(+145.8%) | $2.44 M(+42.7%) |
| Mar 2021 | - | $509.00 K(+150.7%) | $1.71 M(+10.4%) |
| Dec 2020 | $1.55 M(+59.0%) | $203.00 K(-57.2%) | $1.55 M(+15.1%) |
| Sept 2020 | - | $474.00 K(-9.2%) | $1.34 M(+54.5%) |
| June 2020 | - | $522.00 K(+50.0%) | $870.00 K(+150.0%) |
| Mar 2020 | - | $348.00 K | $348.00 K |
| Dec 2019 | $973.00 K | - | - |
FAQ
- What is Cytek Biosciences annual capital expenditures?
- What is the all time high annual CAPEX for Cytek Biosciences?
- What is Cytek Biosciences annual CAPEX year-on-year change?
- What is Cytek Biosciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cytek Biosciences?
- What is Cytek Biosciences quarterly CAPEX year-on-year change?
- What is Cytek Biosciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Cytek Biosciences?
- What is Cytek Biosciences TTM CAPEX year-on-year change?
What is Cytek Biosciences annual capital expenditures?
The current annual CAPEX of CTKB is $4.83 M
What is the all time high annual CAPEX for Cytek Biosciences?
Cytek Biosciences all-time high annual capital expenditures is $9.87 M
What is Cytek Biosciences annual CAPEX year-on-year change?
Over the past year, CTKB annual capital expenditures has changed by -$5.04 M (-51.08%)
What is Cytek Biosciences quarterly capital expenditures?
The current quarterly CAPEX of CTKB is $1.00 M
What is the all time high quarterly CAPEX for Cytek Biosciences?
Cytek Biosciences all-time high quarterly capital expenditures is $6.61 M
What is Cytek Biosciences quarterly CAPEX year-on-year change?
Over the past year, CTKB quarterly capital expenditures has changed by -$390.00 K (-28.00%)
What is Cytek Biosciences TTM capital expenditures?
The current TTM CAPEX of CTKB is $4.39 M
What is the all time high TTM CAPEX for Cytek Biosciences?
Cytek Biosciences all-time high TTM capital expenditures is $9.88 M
What is Cytek Biosciences TTM CAPEX year-on-year change?
Over the past year, CTKB TTM capital expenditures has changed by -$5.49 M (-55.58%)